Drug Shortage Report for ONDANSETRON INJECTION, USP

Last updated on 2018-10-20 History
Report ID 13614
Drug Identification Number 02390019
Brand name ONDANSETRON INJECTION, USP
Common or Proper name ONDANSETRON INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ONDANSETRON
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2ML 5VL
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-17
Estimated end date 2018-10-30
Actual end date 2018-10-19
Shortage status Resolved
Updated date 2018-10-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2018-10-20 English Compare
v14 2018-10-19 French Compare
v13 2018-10-19 English Compare
v12 2018-10-16 French Compare
v11 2018-10-16 English Compare
v10 2018-10-03 French Compare
v9 2018-10-03 English Compare
v8 2018-10-01 French Compare
v7 2018-10-01 English Compare
v6 2018-09-24 French Compare
v5 2018-09-24 English Compare
v4 2017-09-08 French Compare
v3 2017-09-08 English Compare
v2 2017-06-22 French Compare
v1 2017-06-22 English Compare

Showing 1 to 15 of 15